TRV GP IV, LLC
- SEC CIK
- 0001688325
- Latest filing
- Aug 7, 2026
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 14, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 5
- 0 vs. Q3 2022
- Portfolio value
- $235.2M
- +$64.0M (+37.4%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TNGXTango Therapeutics, Inc. | COM | 19,363,975 | $140.4M | 59.7% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,132,867 | $41.2M | 17.5% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 1,419,900 | $33.8M | 14.4% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 2,343,154 | $17.1M | 7.3% | 00.0% | Unchanged | History |
| DNTHDianthus Therapeutics, Inc. | COM | 6,758,204 | $2.67M | 1.1% | 00.0% | Unchanged | History |